The American Diabetes Association found itself in an extraordinary bind last week. Security officers escorted five respected researchers out of its flagship scientific sessions in New Orleans. Their offense? Handing out copies of an editorial their own journal had published weeks earlier.
The piece, titled “Misguided Brushes of a Pen Continue to Dismantle America’s Biomedical Research Enterprise,” laid out concerns over federal cuts and policy shifts under the Trump administration. Diabetes Care ran it in April. Among its authors sat Steven Kahn, the journal’s editor-in-chief and a professor of medicine at the University of Washington.
But the conference atmosphere turned tense quickly. Jay Bhattacharya, then-nominee for National Institutes of Health director, had been slated as keynote speaker. He withdrew the day before, citing a meeting with President Trump. The editorial’s distribution struck some ADA leaders as disruptive. Officers moved in. A video captured the moment. One officer placed hands on a scientist. The group included Kahn, Desmond Schatz, Erin Kelly, Maureen Gannon, and Justin Ryder.
Outrage followed fast. Clinicians and investigators voiced disbelief. Jeffrey Flier, former dean of Harvard Medical School, told STAT News the removal represented “a horrifying mistake.” He added that ADA leadership missed an early chance to correct course with a clear apology.
Initial statements from the organization defended the expulsions. Officials cited a code of conduct that attendees accept upon registration. The behavior, they said, failed to keep the meeting “safe, productive, and centred on advancing diabetes science.” That explanation satisfied few. Criticism mounted across academic circles and major outlets.
The New York Times reported police involvement. The Washington Post highlighted that the scientists included the editor of a leading journal. Bloomberg News noted several worked with major pharmaceutical companies. The story spread. MedPage Today broke it first.
Pressure built. On June 10, ADA CEO Charles “Chuck” Henderson released a video statement. He addressed the researchers by name. “I want to personally apologize to Dr. Steven Kahn, Dr. Desmond Schatz, Dr. Erin Kelly, Dr. Maureen Gannon, and Dr. Justin Ryder, who were escorted out and denied access to scientific sessions,” he said, according to the YouTube posting. Henderson extended the apology to the wider diabetes community.
The reversal came with consequences. Science magazine reported that several ADA officials resigned in the episode’s wake. The organization pledged to rebuild trust. Yet the damage lingers. Longtime members worry the episode signals deeper hesitation to defend open scientific exchange when policy questions arise.
The editorial itself warned of real risks. Trump administration actions, it argued, threatened progress against diabetes and related conditions. Funding constraints at NIH, shifting priorities, and regulatory changes could slow new therapies. Researchers who rely on federal grants felt exposed. Kahn had planned to distribute a thousand copies. He wanted to rally those who saw their work endangered.
But distribution at the conference crossed an invisible line for organizers. They viewed the materials as protest rather than scholarship. The five scientists disagreed. They saw an editorial from the association’s own journal as fair game for discussion at its premier gathering.
Lee C. Rogers, chief of podiatry at UT Health San Antonio, called for exactly the apology that later arrived. In a public letter he urged the ADA to affirm that scientific discourse must remain welcome, even on topics touching public policy. His words captured the sentiment of many. The organization, he wrote, owed the removed scientists a clear commitment that future meetings would protect such conversations.
Henderson’s statement tried to draw that line. He acknowledged the decision to remove the group fell short of the association’s values. The ADA, he said, exists to advance science and improve lives. Ejecting members for sharing peer-reviewed content undermined that mission. Some viewed the apology as genuine. Others saw it as damage control after the backlash grew too loud to ignore.
The episode exposes tensions that extend beyond one conference. Biomedical research depends on federal support. Policy debates inevitably enter professional meetings. Professional societies must balance neutrality with the reality that their members feel the impact of Washington decisions directly. When those societies appear to silence dissent, trust erodes.
And erode it did. Social media lit up with criticism. X posts from journalists and researchers amplified the story. Bloomberg’s coverage on June 10 captured the shift from expulsion to apology and resignations. The speed surprised even seasoned observers.
Diabetes care sits at a delicate juncture. New obesity drugs show promise. Complications from the disease still devastate millions. Progress requires stable funding and open debate. When an organization known for uniting clinicians and scientists instead ejects some of its own, questions arise about its leadership and direction.
The five removed scientists returned to their institutions. Their work continues. Kahn still edits Diabetes Care. Ryder pursues pediatric obesity research at Northwestern. The others maintain prominent roles. Their removal, however brief, sent ripples through the field.
Whether the ADA can restore confidence remains uncertain. Henderson promised changes. He committed to clearer guidelines and better protection for scientific exchange. Yet words alone may not suffice. Actions at next year’s sessions will matter more.
Professional societies have faced similar tests before. They rarely emerge unscathed when they appear to prioritize political caution over open inquiry. This case carries extra weight. The ADA influences clinical guidelines, research funding priorities, and patient advocacy at the highest levels. Its credibility matters.
So the organization apologizes. Officials resign. And the community watches closely. The incident may fade. Its lessons probably will not. Scientific organizations exist to foster discovery, not police opinion. When they forget that distinction, even temporarily, the cost proves high.
Recent coverage from Science details the resignations that accompanied the apology. The piece underscores how quickly internal accountability followed public pressure. Other outlets continue to track fallout. The story, it seems, has not yet run its course.
WebProNews is an iEntry Publication